These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11485406)

  • 61. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.
    Watanabe S; Noda T; Halfmann P; Jasenosky L; Kawaoka Y
    J Infect Dis; 2007 Nov; 196 Suppl 2():S284-90. PubMed ID: 17940962
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ebola virus: from discovery to vaccine.
    Feldmann H; Jones S; Klenk HD; Schnittler HJ
    Nat Rev Immunol; 2003 Aug; 3(8):677-85. PubMed ID: 12974482
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
    Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
    Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.
    Gibb TR; Bray M; Geisbert TW; Steele KE; Kell WM; Davis KJ; Jaax NK
    J Comp Pathol; 2001 Nov; 125(4):233-42. PubMed ID: 11798240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription.
    Hoenen T; Jung S; Herwig A; Groseth A; Becker S
    Virology; 2010 Jul; 403(1):56-66. PubMed ID: 20444481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Hope for a vaccine against ebola virus].
    Holzgrabe U
    Pharm Unserer Zeit; 2001; 30(3):185-6. PubMed ID: 11400662
    [No Abstract]   [Full Text] [Related]  

  • 69. Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs.
    Richardson JS; Abou MC; Tran KN; Kumar A; Sahai BM; Kobinger GP
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1032-42. PubMed ID: 21987739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
    Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
    Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
    [TBL] [Abstract][Full Text] [Related]  

  • 71. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
    Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.
    Lehrer AT; Wong TS; Lieberman MM; Johns L; Medina L; Feldmann F; Feldmann H; Marzi A
    Vaccine; 2019 Nov; 37(47):6942-6950. PubMed ID: 31324500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
    Bray M; Davis K; Geisbert T; Schmaljohn C; Huggins J
    J Infect Dis; 1999 Feb; 179 Suppl 1():S248-58. PubMed ID: 9988191
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ; Altamura LA; Schmaljohn CS
    Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.
    Licata JM; Johnson RF; Han Z; Harty RN
    J Virol; 2004 Jul; 78(14):7344-51. PubMed ID: 15220407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
    Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
    J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunization for Ebola virus infection.
    Xu L; Sanchez A; Yang Z; Zaki SR; Nabel EG; Nichol ST; Nabel GJ
    Nat Med; 1998 Jan; 4(1):37-42. PubMed ID: 9427604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein.
    Li D; Li P; Song N; Jiang Y; Zeng Y; Zhao G; Fa Y; Ye H; Lone Y; Zhou Y; Sun S; Zeng L
    Microbes Infect; 2019; 21(1):56-62. PubMed ID: 29775667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse.
    O'Brien LM; Stokes MG; Lonsdale SG; Maslowski DR; Smither SJ; Lever MS; Laws TR; Perkins SD
    Virology; 2014 Mar; 452-453():324-33. PubMed ID: 24461913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.
    Biedenkopf N; Schlereth J; Grünweller A; Becker S; Hartmann RK
    J Virol; 2016 Aug; 90(16):7481-7496. PubMed ID: 27279615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.